Recommended Reading

Abbasi, K. and R. Smith, No more free lunches, BMJ 326 (7400) : 1155-1156, 29 May 2003

American Academy of Pediatrics, Working Group on cord Blood Banking, Cord Blood Banking for Future Transplantation: Subject Review (RE9860), Pediatrics 104 (1): 116-118, July 1999.

Barr, R.D. the Importance of Lowering the Costs of Stem Cell Transplantation in Developing Countries, International Journal of Hematology, Supplement I (76), 2002

Beaglehole, R. and D.Yach, Globalisation and the prevention and control of non-communicable disease: the neglected chronic disease of adults, Lancet, 362: 903-908, 13 September, 2003.

Burgio, G.R. et al, Ethical reappraisal of 15 years of cord blood transplantation, Lancet 2003: 361: 250-52.

Children 'left to die in agony' BBC News UK Edition, 15 February 2004,
http://news.bbc.co.uk/1/hi/health/3485753.stm

Common Cause, Prescription for Power: How Brand-Name Drug Companies Prevailed Over Consumers in Washington, Washington D.C.: Common Cause Education Fund, 2001.
http://www.commoncause.org

Council for International Organizations of Medical Sciences International Ethical Guidelines for Biomedical Research Involving Human Subjects, Geneva: CIOMS, 2002.
http://www.cioms.ch/frame_guidelines_nov_2002.htm

Families USA, Profiting from Pain: Where Prescription Drug Dollars Go, publication No. 02-105, July 2002.
http://www.familiesusa.org/site/PageServer?pagename
=Prescription_Drugs_Drug_Industry

Florida Hospital Association, Care for Uninsured Non-Citizens: A Growing Burden on Florida Hospitals, February 2003 (Updated)
http://www.fha.org/allproducts.html

Goozner, M., The $800 Million Pill: the Truth Behind The Cost of New Drugs, Berkeley: Univ. of California Press, 2004.

Guilloux, A. and Moon, S. Hidden Price Tags: Disease Specific Drug Donations: Costs and Alternatives, MSF/DND Working Group Expert Paper, Geneva, February 2001.
http://www.accessmed-msf.org/prod/publications.asp?scntid=
2092002185426&contenttype=PARA&

Health Action International Europe, Public-private “Partnerships Addressing Public Health Needs or Corporate Agendas? Seminar report, 2001.
http://www.haiweb.org/pubs/public.html

Health Action International, The Ties that Bind? Weighing the Risks and Benefits of Pharmaceutical Industry Sponsorship, HAI Seminar, Paris, 11 December 1998.
http://www.haiweb.org/pubs/public.html

Health Hazard: Case studies of Big Pharma’s sharp practice, New Internationalist 362: 26-27, November 2003.

Herxheimer, A., Relationships between the pharmaceutical industry and patients’ organisations, BMJ 326: 1208-1210, 31 May 2003.

Hewitt, M. and Simone, J. (eds.), Ensuring Quality Cancer Care, National Cancer Policy Board, Institute of Medicine and Commission on Life Sciences, National Research Council. Washington: National Academy Press, 1999.

Hick, S.F, and McNutt, J.G. (eds.), Advocacy, Activism, and the Internet: Community Organization and Social Policy, Chicago: Lyceum Books, 2002.

Hyder, A.A., et al. Ethical review of health research: a perspective from developing, country researchers J Med Ethics 2004; 30:68

Int J Health Serv. 2003, 33(1):29-36.

Kelleher, K., Who Pays for What? Acumen Journal of Life Sciences, 2 (1): 31-6, January/February 2004.

Loewy, M.A., Cancer Drug Trials Questioned in Argentina, Reuters Health, May 23, 2003.
http://lists.essential.org/pipermail/ip
-health/2003-May/004799.html

Lurie, P. and S.M. Wolf, Globalization of clinical trials: Comments on the Draft Health and Human Services Inspector General's Report: The Globalization of Clinical Trials, HRG Publication #1591, Public Citizen, 2001.
http://www.comite.bioetica.org/biblio10.htm

Making Cancer Health Disparities History, Report of the Trans-HHS Cancer Health Disparities Progress Review Group, Submitted to the Secretary, US HHS, march 2004.
http://www.chdprg.omhrc.gov/pdf/chdprg.pdf

Mills, F. Patient Groups and the Global Pharmaceutical Industry: The Growing Importance of Working Directly with the Consumers, London: Informa Publishing, 2000.
http://www.pdci.on.ca/reports/patientgroups.htm

National immigration Law Center, Guide to Immigrant Eligibility for Federal Programs, 4th edition, Los Angeles, NILC Publications, 2002

National Standards for Culturally and Linguistically Appropriate Services in health Care, US Dept. of Health & Human Services, 2001. Office of Minority Health, Full Report and Commentary.
http://www.omhrc.gov/clas/cultural1a.htm.

Ramos, J.D. Help for Uninsured children with Cancer APOSW Update 29 (1): 4-5, 9, Winter 2004.
http://www.aposw.org

Ramos, J.D., Who Cares about Cancer? New Internationalist, 362: 24-25, November, 2003.

Scheffler, R.M. and Andrews, N.C., Cancer Care and Cost: DRGs and Beyond, Ann Arbor: Health Administration Press Perspectives, 1989.

Schlosberg, C., Immigrant Access to Health Benefits: A Resource Manual, Boston: The Access Project, 2000.

Shah, S., Globalization of clinical research by the pharmaceutical industry.

Smith, J., Food, flattery, and friendship, BMJ 326: 0, 29 May 2003.

Strom, S. and M. Fleischer-Black, Company’s Pledge to Donate a Drug is Falling Short, The New York Times, 5 June 2003, A 1, C 11.

The Unequal Burden of Cancer: An Assessment of NIH Research and Programs for Ethnic Minorities and the Medically Underserved. Committee on Cancer Research among Minorities and the Medically Underserved, Health Sciences Policy Program, Health Sciences Section, Institute of Medicine, National Academy Press, Washington, D.C. 1999.
http://www.nap.edu/books/0309071542/html/.

Thomas, A., Street Price: A Global Approach to Drug Pricing for Developing Countries, VSO Position Paper, London: Voluntary Service Organization, [2003]
http://www.vso.org.uk/Images/position_papers_street_price_tcm8-1605.pdf

Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare. Committee of Understanding and Eliminating Racial and Ethnic Disparities in Healthcare, Board on Health Sciences Policy. Institute of Medicine, Washington: National Academies Press, 2003.
http://www.nap.edu/books/030908265X/html/.

Voices of a Broken System: Real People, Real Problems. President’s Cancer Panel. Report of the chairman, 2000-2001. Bethesda, MD. 2003.
http://deainfo.nci.nih.gov/ADVISORY/pcp/video-summary.htm

WHO et al., WHO, Department of Essential Drugs and Other Medicines, Guidelines for Drug Donations, Revised 1999.
http://www.drugdonations.org/eng/richtlijnen/eng
_geneesmiddelendonatiesrich.html

WHO, Globalization, TRIPS, and access to pharmaceuticals, WHO Policy Perspectives on Medicines, No. 3, March 2001
http://www.who.int/medicines/organ
ization/mgt/trips_med.shtml

WHO. Human organ and tissue transplantation, Report by the Secretariat, 57th World Health Assembly, provisional agenda item 12.14, A57/17, 8 April 2004.
http://www.who.int/ethics/topics/human_transplant/en/

Wood, B., Patient Power? The Politics of Patients’ Associations in Britain and America, Philadelphia/ Buckingham: Open University Press, 2000.

World Health Organization & Health Action International, Medicine Prices: A New Approach to Measurement. Working draft for field testing and revision. 2003.
http://www.haiweb.org/medicineprices/

Young, N. S. Hematological Disorders in the Developing World, Hematology 1999: 58-63.

Zakarian, B., The Activist Cancer Patient, New York: Wiley, 1996.